TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 2 | -3 | 15 | 13 | 6 | -21 | -37 | -4 |
| P | %wins | 0 | 50 | 50 | 50 | 50 | 50 | 42 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
4/17/14 11:38 | 4/14/14 | APPY | Venaxis, Inc. | CO | Health | Diagn | In Vitro & In Vivo Diagnostic | Hurd Donald R | CO | O | SVP,Chie | P | 71 | 2.04 | 0 | 35 | 233 | 50 | D | -43 | 23 | 26 | -8 | -11 | -8 | 11 | 14 | -3 | -6 | -15 | -14 | -48 | -79 |
9/24/12 13:46 | 9/21/12 | APPY | Aspenbio Pharma, Inc. | CO | Health | Diagn | In Vitro & In Vivo Diagnostic | Hurd Donald R | CO | O | SVP,Chie | P | 30 | 1.99 | 0 | 15 | New | 15 | D | -86 | -88 | -52 | 2 | 28 | 36 | 9 | 4 | -2 | 36 | 40 | 26 | 6 | 6 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |